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ABSTRACT
Methicillin susceptibility of 415 staphylococcal
isolates from Chinese hospitals was assessed
using the CLSI disk-diffusion method with a
cefoxitin 30-lg disk in comparison with an oxa-
cillin 1-lg disk. PCR-based detection of mecA was
the reference standard. The cefoxitin 30-lg disk
performed with almost the same high level of
accuracy as the oxacillin 1-lg disk in detecting
methicillin resistance in Staphylococcus aureus. For
coagulase–negative staphylococci (CoNS), the
sensitivity of the cefoxitin 30-lg disk was 90.5%,
compared with 83.4% for the oxacillin 1-lg disk.
Conﬁrmatory testing of isolates with borderline
susceptibility and revision of the cefoxitin break-
point are proposed in order to categorise CoNS
more accurately.
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Penicillin-binding protein (PBP) 2a, encoded by
the mecA gene, is the main cause of methicillin
resistance in staphylococci [1]. Since methicillin-
resistant staphylococci have become widely
prevalent, the glycopeptide antibiotic vancomy-
cin has become the most common treatment for
staphylococcal infections. The emergence of
Staphylococcus aureus and coagulase-negative sta-
phylococci (CoNS) with resistance to glycopep-
tides emphasises the importance of the prudent
use of antibiotics and the need for reliable
laboratory identiﬁcation of methicillin-resistant
strains [2,3]. A variety of testing methods for
the detection of methicillin-resistant S. aureus
(MRSA) have been developed [4–8]. However,
the reliability of methicillin susceptibility testing
for CoNS isolates is currently a major concern
because of the more heterogeneous expression
of the mecA gene [9]. Use of a cefoxitin disk has
recently been proposed as an alternative to an
oxacillin disk for detecting methicillin resistance
in staphylococci [10–17]. In the present study,
tests using cefoxitin 30-lg disks were compared
to tests using oxacillin 1-lg disks by the CLSI
(formerly NCCLS) method [18]. PCR-based
detection of mecA was used as the reference
standard.
In total, 415 epidemiologically unrelated clinic-
ally signiﬁcant isolates (178 S. aureus and 237
CoNS) were recovered (January–May 2003) from
hospitalised patients in all departments, including
the intensive care units, of several hospitals in
China (Beijing Hospital, Beijing Tiantan Hospital,
Beijing Tongren Hospital and Peking Union Med-
ical College Hospital). Duplicate samples from the
same patient were excluded. Methicillin-resistant
isolates were selected on the basis of oxacillin
resistance, as determined by the CLSI disk-diffu-
sion method [18], and methicillin-susceptible
isolates were selected randomly. Among the
isolates, 145 (34.9%) were from blood, 110
(26.5%) were from pus, 92 (22.2%) were from
the respiratory tract, and 44 (10.6%) were from
urine. All the S. aureus and CoNS isolates were
identiﬁed to the species level with the Vitek 2
instrument (bioMe´rieux, Rouen, France). For
CoNS, the collection comprised 144 Staphylococcus
epidermidis, 41 Staphylococcus haemolyticus, 18 Sta-
phylococcus auricularis, 13 Staphylococcus simulans,
seven Staphylococcus hominis, four Staphylococcus
capitis, four Staphylococcus sciuri and six uniden-
tiﬁed CoNS isolates.
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Antimicrobial susceptibility was tested by the
CLSI disk-diffusion method [18] on Mu¨eller–
Hinton agar with oxacillin 1-lg and cefoxitin 30-
lg disks (Tiantan Biotechnology Co., Beijing,
China). Plates were incubated for 24 h at 35C
before measuring inhibition zone diameters.
S. aureus ATCC 25923 was included as a control
strain; inhibition zone diameters with oxacillin
1-lg disks and cefoxitin 30-lg disks were within
the published limits (19–24 mm and 23–29 mm,
respectively). PCR for the mecA gene used prim-
ers mecA-f (5¢- GATGGCTATCGTGTCACAATC)
and mecA-r (5¢-TGAGTTGAACCTGGTGAAGT)
to generate a 352-bp amplicon. Of the 178 S. aureus
isolates, 119 were mecA-positive and 59 were
mecA-negative. Of the 237 CoNS, 199 were mecA-
positive and 38 were mecA-negative. All the PCR
products were further validated by hybridisation
using gene-speciﬁc probes (results not shown).
The relationship between the disk-diffusion
results and mecA status is summarised in Table 1.
The current CLSI breakpoints for cefoxitin and
oxacillin both separated the resistant and suscept-
ible populations of S. aureus with satisfactory
accuracy, as reported previously [10–12]. The
sensitivities of the oxacillin 1-lg disk and the
cefoxitin 30-lg disk tests were 97.5% and 96.6%,
and the speciﬁcities were 98.3% and 94.9%,
respectively. With most isolates, the inhibition
zone diameters for mecA-positive and mecA-neg-
ative S. aureus were distinct with both agents.
The oxacillin zone diameters for mecA-positive
S. aureus were 6–10 mm, and for mecA-negative
S. aureus were 15–30 mm, except for three false-
susceptible isolates (zone diameters 14, 15 and
16 mm, respectively) and one false-resistant iso-
late (zone diameter 6 mm). The cefoxitin zone
diameters for mecA-positive S. aureus were
6–19 mm and for mecA-negative S. aureus were
20–32 mm, except for four false-susceptible iso-
lates (zone diameters 20 mm for three and 23 mm
for one) and three false-resistant isolates (zone
diameters 6 mm for two and 19 mm for one). One
mecA-positive and one mecA-negative S. aureus
gave discrepant results with both oxacillin and
cefoxitin. There was no obvious explanation for
the mecA-negative isolates with no zone of inhi-
bition to oxacillin or cefoxitin, but the results were
reproducible. In addition, three of six false-sus-
ceptible S. aureus isolates were shown by RAPD
analysis to be related genotypically (data not
shown).
With the 237 CoNS isolates, the cefoxitin 30-lg
disk test (sensitivity 90.5%) was signiﬁcantly
more accurate (p < 0.05 by Mann–Whitney U-
test) than the oxacillin 1-lg disk test (sensitivity
83.4%). Numerous discrepancies were seen,
particularly among mecA-positive, oxacillin-sus-
ceptible or cefoxitin-susceptible isolates (Fig. 1).
Among 199 mecA-positive CoNS isolates, 19
(9.5%) with distinct RAPD patterns were classi-
ﬁed falsely as susceptible in the cefoxitin test. In
the present study, the sensitivity of the tests with
CoNS was lower than that reported by Swenson
et al. [15]. The inhibition zone diameters of many
isolates were within 1 mm of the breakpoints
(Fig. 1), resulting in poor separation of the
resistant and susceptible populations, and conse-
Table 1. Detection of methicillin resistance in 415 clinical isolates of staphylococci by disk-diffusion with oxacillin and
cefoxitin disks
Organism Agent tested
Susceptibility
by disk-diffusion
Number of isolates
Sensitivitya (%) Speciﬁcityb (%)mecA + mecA –
Staphylococcus aureus n = 119 n = 59
Oxacillin R 116 1c 97.5 98.3
S 3c 58
Cefoxitin R 115 3c 96.6 94.9
S 4c 56
CoNS n = 199 n = 38
Oxacillin R 166 9c 83.4 76.3
S 33c 29
Cefoxitin R (CLSI) 180 8c 90.5 ⁄ 97.0 78.9 ⁄ 71.1
R (proposed breakpoints)d 193 11c
S 19c 30
S (proposed
breakpoints)d
6c 27
R, resistant; S, susceptible; CoNS, coagulase-negative staphylococci.
aSensitivity was calculated as the number of isolates with true-positive results ⁄ the number of mecA-positive isolates.
bSpeciﬁcity was calculated as the number of isolates with true-negative results ⁄ the number of mecA-negative isolates.
cIndicates isolates with a discrepancy between the phenotypic test and the mecA status determined by PCR.
dS = 27 mm; R = 26 mm.
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quently, some incorrect results (13 of the isolates
with zones within 1 mm of the breakpoint for
each agent). Furthermore, of the 13 mecA-negative
CoNS isolates that were categorised as resistant
by either the cefoxitin or the oxacillin test, MICs of
oxacillin, determined by the CLSI agar dilution
method [19], were 0.5 to >16 mg ⁄L for 12 isolates,
indicating that resistance mechanisms other than
that mediated by mecA were present.
In order to improve the reliability of oxacillin
and cefoxitin disk-diffusion tests using the CLSI
method, a PCR test for mecA or a latex agglutin-
ation test for PBP2a should be performed on any
CoNS isolate with an oxacillin zone diameter of
17–27 mm, or a cefoxitin zone diameter of 24–
31 mm. As suggested previously [17], the present
data also indicate that breakpoints of S ‡27 mm
and R £26 mm for the cefoxitin 30-lg disk would
provide a high sensitivity (97.0%) with CoNS, but
at the expense of speciﬁcity (71.1%).
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ABSTRACT
Restriction fragment length polymorphism
(RFLP) analysis can be used to assess genetic
relatedness of Mycobacterium tuberculosis isolates.
This study reports a collaborative investigation of
false-positive cultures for M. tuberculosis, suspec-
ted when the DNA ﬁngerprint from an index case
matched an epidemiologically improbable source
case. RFLP analysis matched ﬁngerprints in ten of
16 cases of suspected laboratory contamination to
four separate smear-positive sources that were
processed on the same day in the same laboratory.
All single smear-negative, positive cultures pro-
cessed on the same day as smear-positive speci-
mens should be reviewed on a case-by-case basis
to identify possible false-positive cultures.
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A clinical diagnosis of tuberculosis (TB) is,
ideally, conﬁrmed with a positive culture. Even
in cases without symptoms or with a normal
chest radiograph, a positive culture constitutes
an active case in need of treatment, as coloni-
sation with Mycobacterium tuberculosis is not
thought to occur. Recent advances have im-
proved the diagnosis of TB, but have been
associated with a parallel rise in the number of
reports of false-positive cultures [1,2]. Laborat-
ory cross-contamination is a well-documented
source of false-positive cultures, which have
important clinical and public health conse-
quences [3–10]. Diagnostic criteria for suspected
laboratory cross-contamination with M. tubercu-
losis have been published [11,12], and the recent
rise in the number of reports is probably related
to the ease with which these incidents can be
conﬁrmed by molecular epidemiological studies
[13,14]. The present report describes a retrospec-
tive collaborative investigation of four clusters
of false-positive TB cultures caused by probable
laboratory cross-contamination. The investiga-
tion was initiated when the restriction fragment
length polymorphism (RFLP) cluster results for
a case could not be explained by epidemiolog-
ical evaluation.
Between December 2001 and January 2003, 84
M. tuberculosis isolates from 44 patients were
identiﬁed by laboratory culture according to
published guidelines [15,16]. Laboratory contam-
ination was considered if patients had a single
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